The anti-obesity effects of GALP may be due to the sympathetic nervous system-mediated suppression of appetite in peripheral tissues together with inhibition of fatty acid β-oxidation and fatty acid synthesis [8,9,10]. The gene discussed is GALP; the disease is obesity disorder.